A new service has been launched in the US that sends email alerts about counterfeit drugs in a bid to ensure the safety of prescription medicines. The free service is the brainchild of the Partnership for Safe Medicines, a coalition of patient, physician, pharmacist, university, industry and professional organizations. It works by monitoring government counterfeit alerts and disseminating relevant information to the public, eliminating the need for consumers to actively research fake drugs on government web sites.
